Regulation of endogenous dopamine release in amphibian retina by gamma-aminobutyric acid and glycine.
J H Boatright, N M Rubim, P M Iuvone
https://pubmed.ncbi.nlm.nih.gov/7947393Actively Recruiting
Led by Peking University People's Hospital · Updated on 2026-05-29
66
Participants Needed
1
Research Sites
N/A
Total Duration
This clinical trial investigates how different light conditions affect sedation depth during general anesthesia. The study aims to understand whether light exposure changes the amount of anesthetic drugs needed and the mechanisms behind this effect. Participants are adults aged 18 to 65 years with certain health status and body mass index ranges. Participants are randomly assigned to one of two groups: the light-shielded group or the non-light-shielded group. Those in the light-shielded group wear an opaque eye mask starting 30 minutes before anesthesia and continue wearing it until sedative medications are stopped. The other group receives no intervention related to light exposure. Throughout the surgery, researchers will record induction drug doses, induction time, total anesthetic dosage during surgery, and emergence time from anesthesia. These measurements help assess how light exposure influences anesthesia. The study runs until June 2026, with follow-up and monitoring during the perioperative period.
CONDITIONS
Light and Anesthesia
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Perioperative period
Participants in the light-shielded group wear an opaque eye mask 30 minutes prior to induction of general anesthesia and continue to do so until the sedative medications are stopped.
1 perioperative visit (in-person)
Total: 1 location
1
Peking University People's Hospital
Beijing, China, 100044
Actively Recruiting
Y
Yi Feng, Ph.D
X
Xiaoyan Li, Ph.D
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
J H Boatright, N M Rubim, P M Iuvone
https://pubmed.ncbi.nlm.nih.gov/7947393J Szolnoki, D M Polaner, T Eckle
https://pubmed.ncbi.nlm.nih.gov/30236240Jiang-Hua Shen, Min Ye, Qian Chen...
https://pubmed.ncbi.nlm.nih.gov/34488646Dan Wang, Yujie Huang, Xinxin Wang...
https://pubmed.ncbi.nlm.nih.gov/32807382Yingqi Shao, Yao Li, Nan Wang...
https://pubmed.ncbi.nlm.nih.gov/38253963Masao Ishizawa, Takuya Uchiumi, Miki Takahata...
https://pubmed.ncbi.nlm.nih.gov/34217920Yvan Touitou, Alain Reinberg, David Touitou
https://pubmed.ncbi.nlm.nih.gov/28214594Laura K Barger, Jason P Sullivan, Steven W Lockley...
https://pubmed.ncbi.nlm.nih.gov/33065729A Daurat, J Foret, O Benoit...
https://pubmed.ncbi.nlm.nih.gov/11025337Hannah K Dollish, Mariya Tsyglakova, Colleen A McClung
https://pubmed.ncbi.nlm.nih.gov/37858331